Literature DB >> 30711356

Risk factors for acne development in the first 2 years after initiating masculinizing testosterone therapy among transgender men.

Jason Andrew Park1, Erin Elizabeth Carter1, Allison Ruth Larson2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30711356     DOI： 10.1016/j.jaad.2018.12.040

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

Review 1.  Acne and the Lesbian, Gay, Bisexual, or Transgender Teenager.

Authors:  Laura Ragmanauskaite; Benjamin Kahn; BaoChau Ly; Howa Yeung
Journal:  Dermatol Clin       Date:  2019-11-26       Impact factor: 3.478

2.  Treating Acne in Transgender Persons Receiving Testosterone: A Practical Guide.

Authors:  Rakan Radi; Sarah Gold; Juan P Acosta; Jason Barron; Howa Yeung
Journal:  Am J Clin Dermatol       Date:  2022-01-11       Impact factor: 6.233

Review 3.  Testosterone in men with hypogonadism and transgender males: a systematic review comparing three different preparations.

Authors:  Milou Cecilia Madsen; Martin den Heijer; Claudia Pees; Nienke R Biermasz; Leontine E H Bakker
Journal:  Endocr Connect       Date:  2022-07-25       Impact factor: 3.221

4.  Incidence and Factors Associated With Acne Among Transgender Patients Receiving Masculinizing Hormone Therapy.

Authors:  Nick Thoreson; Jason A Park; Chris Grasso; Jennifer Potter; Dana S King; Linda G Marc; Changyu Shen; J Klint Peebles; Erica D Dommasch
Journal:  JAMA Dermatol       Date:  2021-03-01       Impact factor: 10.282
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.